24
total announcements
543322.BO · 15 min delayed
Alivus Life Sciences Ltd
Alivus Life Sciences Ltd has announced an earnings call for Q1 FY2026-27 on July 31, 2026, to discuss its financial performance.
Alivus Life Sciences Ltd
Alivus Life Sciences Ltd has announced the closure of the trading window from July 1, 2026 to August 1, 2026, for the purpose of approving unaudited financial results for the quarter ended June 30, 2026.
Alivus Life Sciences Ltd
Alivus Life Sciences Ltd has scheduled a Board Meeting on July 30, 2026, to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2026.
Alivus Life Sciences Ltd
Alivus Life Sciences Ltd (formerly Glenmark Life Sciences Limited) has announced an institutional investor meeting in the form of a plant visit scheduled for June 29, 2026, at its Ankleshwar, Gujarat facility. This visit, which may be a group or one-on-one meeting, is to facilitate engagement with institutional investors. The company noted that the schedule and mode could change due to exigencies.